297 related articles for article (PubMed ID: 25720799)
1. High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity.
Chen M; Liu Y; Varley P; Chang Y; He XX; Huang H; Tang D; Lotze MT; Lin J; Tsung A
Cancer Res; 2015 Apr; 75(8):1645-56. PubMed ID: 25720799
[TBL] [Abstract][Full Text] [Related]
2. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994
[TBL] [Abstract][Full Text] [Related]
3. miR-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression.
Fu Y; Sun LQ; Huang Y; Quan J; Hu X; Tang D; Kang R; Li N; Fan XG
Curr Mol Med; 2018; 18(3):135-141. PubMed ID: 30198432
[TBL] [Abstract][Full Text] [Related]
4. Extracellular HMGB1 promotes CD44 expression in hepatocellular carcinoma via regulating miR-21.
Li J; Ren H; Wang J; Zhang P; Shi X
Aging (Albany NY); 2021 Mar; 13(6):8380-8395. PubMed ID: 33661757
[TBL] [Abstract][Full Text] [Related]
5. miR-505 enhances doxorubicin-induced cytotoxicity in hepatocellular carcinoma through repressing the Akt pathway by directly targeting HMGB1.
Lu L; Zhang D; Xu Y; Bai G; Lv Y; Liang J
Biomed Pharmacother; 2018 Aug; 104():613-621. PubMed ID: 29803174
[TBL] [Abstract][Full Text] [Related]
6. The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1.
Li H; Huang W; Luo R
Diagn Pathol; 2015 Jul; 10():117. PubMed ID: 26194496
[TBL] [Abstract][Full Text] [Related]
7. miR-320a regulates high mobility group box 1 expression and inhibits invasion and metastasis in hepatocellular carcinoma.
Lv G; Wu M; Wang M; Jiang X; Du J; Zhang K; Li D; Ma N; Peng Y; Wang L; Zhou L; Zhao W; Jiao Y; Gao X; Hu Z
Liver Int; 2017 Sep; 37(9):1354-1364. PubMed ID: 28317284
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-135b, a HSF1 target, promotes tumor invasion and metastasis by regulating RECK and EVI5 in hepatocellular carcinoma.
Li Y; Xu D; Bao C; Zhang Y; Chen D; Zhao F; Ding J; Liang L; Wang Q; Liu L; Li J; Yao M; Huang S; He X
Oncotarget; 2015 Feb; 6(4):2421-33. PubMed ID: 25537516
[TBL] [Abstract][Full Text] [Related]
9. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M
Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846
[TBL] [Abstract][Full Text] [Related]
10. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis.
Yan XL; Jia YL; Chen L; Zeng Q; Zhou JN; Fu CJ; Chen HX; Yuan HF; Li ZW; Shi L; Xu YC; Wang JX; Zhang XM; He LJ; Zhai C; Yue W; Pei XT
Hepatology; 2013 Jun; 57(6):2274-86. PubMed ID: 23316018
[TBL] [Abstract][Full Text] [Related]
12. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3.
Lu Y; Yue X; Cui Y; Zhang J; Wang K
Biochem Biophys Res Commun; 2013 Nov; 441(4):873-9. PubMed ID: 24211205
[TBL] [Abstract][Full Text] [Related]
15. NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α.
Bao C; Li Y; Huan L; Zhang Y; Zhao F; Wang Q; Liang L; Ding J; Liu L; Chen T; Li J; Yao M; Huang S; He X
Sci Signal; 2015 Jul; 8(387):ra75. PubMed ID: 26221053
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus X protein promotes CREB-mediated activation of miR-3188 and Notch signaling in hepatocellular carcinoma.
Zhou SJ; Deng YL; Liang HF; Jaoude JC; Liu FY
Cell Death Differ; 2017 Sep; 24(9):1577-1587. PubMed ID: 28574502
[TBL] [Abstract][Full Text] [Related]
17. HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2.
Chen Y; Lin C; Liu Y; Jiang Y
Tumour Biol; 2016 Apr; 37(4):4399-408. PubMed ID: 26499944
[TBL] [Abstract][Full Text] [Related]
18. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway.
Gu W; Li X; Wang J
Oncol Rep; 2014 Jan; 31(1):397-404. PubMed ID: 24190507
[TBL] [Abstract][Full Text] [Related]
19. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
20. miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.
Wang P; Chen S; Fang H; Wu X; Chen D; Peng L; Gao Z; Xie C
Oncotarget; 2016 Jan; 7(1):929-45. PubMed ID: 26498144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
